Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Small amounts of DNA can be found in the hair shaft, especially near the root, but it decreases with hair treatments and washing.

Some cancer treatments can cause abnormal fine hair growth.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Inflammatory acne damages skin stem cells and reduces their growth, leading to atrophic acne scars.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

A woman with lupus also developed a severe skin condition linked to a genetic factor.